Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Cephalon/Leo neurological disease collaboration

Nov. 20, 1996

Antimigraine drug from Vanguard to enter pivotal trials

Nov. 20, 1996

Peripheral opiate antihyperalgesic from Adolor in clinical trials

Nov. 20, 1996

SKB reports D3-selective antipsychotic agents

Nov. 20, 1996

Analgesic kappa-opioid agonists reported by Pfizer

Nov. 20, 1996

Daiichi discloses cerebroprotective agents

Nov. 15, 1996

IL-6 as a target for Alzheimer's disease drug design

Nov. 15, 1996

New MS treatment approved in Israel

Nov. 15, 1996

AutoImmune's MS therapeutic in final stages of development

Nov. 15, 1996

Rx for Parkinson's disease from NeuroSearch/BMS enters phase II

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...